Cyclophilin A as a novel biphasic mediator of endothelial activation and dysfunction.
about
Antiapoptotic and proapoptotic signaling of cyclophilin A in endothelial cellsThe mitochondrial permeability transition from yeast to mammalsCyclophilin A enhances macrophage differentiation and lipid uptake in high glucose conditions: a cellular mechanism for accelerated macro vascular disease in diabetes mellitusThe Stimulation of CD147 Induces MMP-9 Expression through ERK and NF-kappaB in Macrophages: Implication for Atherosclerosis.Novel approach to inhibit asthma-mediated lung inflammation using anti-CD147 intervention.Exploration of disease mechanism in acute kidney injury using a multiplex bead array assay: a nested case-control pilot studyActivation of CD147 with cyclophilin a induces the expression of IFITM1 through ERK and PI3K in THP-1 cells.Cyclophilin A is associated with peripheral artery disease and chronic kidney disease in geriatrics: The Tianliao Old People (TOP) studyCyclosporin a disrupts notch signaling and vascular lumen maintenance.Proteomic 2D DIGE profiling of human vascular endothelial cells exposed to environmentally relevant concentration of endocrine disruptor PCB153 and physiological concentration of 17β-estradiol.Role of cyclophilin A from brains of prion-infected mice in stimulation of cytokine release by microglia and astroglia in vitroLiver proteomics for therapeutic drug discovery: inhibition of the cyclophilin receptor CD147 attenuates sepsis-induced acute renal failureTargeting extracellular cyclophilins ameliorates disease progression in experimental biliary atresia.Proteomics identification of cyclophilin a as a potential prognostic factor and therapeutic target in endometrial carcinomaCyclophilin A from Schistosoma japonicum promotes a Th2 response in mice.A multidisciplinary approach to study a couple of monozygotic twins discordant for the chronic fatigue syndrome: a focus on potential salivary biomarkers.Cyclophilin A: a key player for human diseasePotential implications of Apolipoprotein E in early brain injury after experimental subarachnoid hemorrhage: Involvement in the modulation of blood-brain barrier integrity.Cyclophilin D in mitochondrial pathophysiology.An overview of cyclophilins in human cancers.Necrotic cell death in atherosclerosis.Extracellular cyclophilins in health and disease.Peptidyl-prolyl isomerases: a full cast of critical actors in cardiovascular diseases.Over-expression and potential role of cyclophilin A in human periodontitis.CD147/EMMPRIN acts as a functional entry receptor for measles virus on epithelial cells.Contribution of cyclophilin A to the regulation of inflammatory processes in rheumatoid arthritis.Inhibition of cyclophilin A suppresses H2O2-enhanced replication of HCMV through the p38 MAPK signaling pathway.Cryptococcus neoformans promotes its transmigration into the central nervous system by inducing molecular and cellular changes in brain endothelial cellsProteome profiling of spinal cord and dorsal root ganglia in rats with trinitrobenzene sulfonic acid-induced colitis.Cyclophilin A secreted from fibroblast-like synoviocytes is involved in the induction of CD147 expression in macrophages of mice with collagen-induced arthritis.The cyclophilin inhibitor Debio 025 normalizes mitochondrial function, muscle apoptosis and ultrastructural defects in Col6a1-/- myopathic mice.Proteome analysis of whole saliva: a new tool for rheumatic diseases--the example of Sjögren's syndrome.[Progress of CypA and lung cancer-related research].Functions of cyclophilin A in atherosclerosis.Association of increased ligand cyclophilin A and receptor CD147 with hypoxia, angiogenesis, metastasis and prognosis of tongue squamous cell carcinoma.Genetic ablation of cyclophilin D rescues mitochondrial defects and prevents muscle apoptosis in collagen VI myopathic mice.A proteomic study of the effects of ramipril on post-infarction left ventricular remodelling in the rabbit.Growth hormone action in the developing neural retina: a proteomic analysis.Acutely increased cyclophilin a expression after brain injury: a role in blood-brain barrier function and tissue preservation.Extracellular Matrix Metalloproteinase Inducer EMMPRIN (CD147) in Cardiovascular Disease.
P2860
Q28279892-251D9A1B-5BC5-44CF-ACF7-D4432691D7C1Q28279895-87AF5950-4118-4A6F-8916-070BBDDD6F6BQ28822277-B9227A0F-0DC7-4789-8E8C-037B25228577Q33578091-A92D0E32-2388-4B53-9B30-B570AB397219Q33792231-A5AAC767-5451-4D97-9D1D-E80F655F11E5Q34009324-55AF4E85-3460-42FB-BFAE-698AF1CC0386Q34109349-EB104730-5729-43DD-AF82-39BC4370B8DDQ35535488-AC6FE4B4-88D7-470F-AC69-68947347A33FQ35578269-62D5C620-622F-4C23-BE5F-D297482274E5Q35580793-E04E0F4C-F040-41D1-96AE-2BC320E470D5Q35763031-1A545AAD-BC66-4FC8-93FC-DCA15D3E6C6AQ36515910-63E462D0-2612-48FE-8F68-CE1E4FCDA311Q36568302-5B207CB5-DCCA-4F15-9BDA-62C6E112E656Q37113899-A0E6D3D6-BEB4-4D56-B192-103710A7346CQ37350101-945E7620-F098-40F0-BB57-0EE82209114BQ37363077-74A1E9B9-95E9-4A13-9D56-D9084FB4858DQ37577487-4EAABB92-80FF-4713-86ED-7F896FABCB6CQ37636579-EBA43D23-A045-4662-A60C-42C0F48F8678Q37660604-643CEA97-0D37-456B-A502-AB480794CA4EQ37839040-802ED103-CD72-43D5-A3DB-34AC29D40392Q37879605-903BF307-C1B5-430D-B2B1-3A0CEBD935A9Q38274888-C0F1135B-051F-4567-8416-BE5106217195Q38370240-3D3DF336-BB1C-4CA9-A3F3-B583E6BDB947Q39188487-847714B2-5254-4FC9-9C1A-47669A063F50Q39741172-92BCFD92-0311-4154-84F6-9ACABD0F9B01Q39793486-EDBA19E6-6099-45D2-81A5-B286284A2363Q40535828-DCC2F713-EDB6-4A0C-AE08-89DAA09771BCQ41886935-76E467DE-E1F7-45F7-9D7C-2DC476B22615Q41928668-B812DBCD-06F8-4110-ABF3-FA1FF777C5EEQ42183843-28823113-FD69-440A-B345-CD70549AE7E1Q42545449-5D723516-17CB-4F6E-A6D9-2D93C9C6C508Q42617298-D37DBA7E-B67A-4061-8E2F-B5AE60539F16Q42939494-D72B9BD8-6EE2-4EBE-B2B4-AAD3124B920CQ43081736-78A0D4A2-E560-4CC3-B460-25D87BC4AB96Q44904871-BF6EA526-97AA-4FC9-A049-0A07206AD6BBQ46085120-CCFD0851-ECC6-4235-BD79-D7F7455360FBQ46516544-C7C90270-B291-43C9-9002-A1221C7B19E6Q46802554-892F8965-CA98-4442-938C-6E99B4E47809Q48187496-726C4162-1CEE-4F42-BF21-887D9B77D48BQ50117655-01817AB9-4677-41C8-9F19-D874BE5CEC25
P2860
Cyclophilin A as a novel biphasic mediator of endothelial activation and dysfunction.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
Cyclophilin A as a novel biphasic mediator of endothelial activation and dysfunction.
@ast
Cyclophilin A as a novel biphasic mediator of endothelial activation and dysfunction.
@en
type
label
Cyclophilin A as a novel biphasic mediator of endothelial activation and dysfunction.
@ast
Cyclophilin A as a novel biphasic mediator of endothelial activation and dysfunction.
@en
prefLabel
Cyclophilin A as a novel biphasic mediator of endothelial activation and dysfunction.
@ast
Cyclophilin A as a novel biphasic mediator of endothelial activation and dysfunction.
@en
P2093
P2860
P1476
Cyclophilin A as a novel biphasic mediator of endothelial activation and dysfunction
@en
P2093
Se-Hwa Kim
Yumiko Sakurai
Zorina S Galis
P2860
P304
P356
10.1016/S0002-9440(10)63715-7
P407
P577
2004-05-01T00:00:00Z